Upgrade to SI Premium - Free Trial

BioXcel Therapeutics (BTAI)

0.07 -0.05 (41.67%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

BioXcel Therapeutics files for Chapter 11, agrees to sell assets to Teva August 28, 2026 6:25 AM - StreetInsider Form 8-K BioXcel Therapeutics, For: Aug 27 August 28, 2026 6:08 AM - SEC Filing BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals August 28, 2026 6:00 AM - Globe NewsWire Form 8-K BioXcel Therapeutics, For: Aug 24 August 25, 2026 7:16 AM - SEC Filing Form 8-K BioXcel Therapeutics, For: Aug 21 August 24, 2026 7:00 AM - SEC Filing Form 4 BioXcel Therapeutics, For: Aug 12 Filed by: Atkins Susan E. August 14, 2026 7:01 PM - SEC Filing Form 3 BioXcel Therapeutics, For: Aug 12 Filed by: Atkins Susan E. August 14, 2026 7:00 PM - SEC Filing Form SCHEDULE 13G/A BioXcel Therapeutics, Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:05 AM - SEC Filing Form 10-Q BioXcel Therapeutics, For: Jun 30 August 13, 2026 4:32 PM - SEC Filing Form 8-K BioXcel Therapeutics, For: Aug 10 August 11, 2026 7:01 AM - SEC Filing Form 8-K BioXcel Therapeutics, For: Jul 31 August 3, 2026 7:00 AM - SEC Filing Form 8-K BioXcel Therapeutics, For: Jul 06 July 6, 2026 6:04 AM - SEC Filing Form 4 BioXcel Therapeutics, For: Jun 15 Filed by: Rodriguez Javier June 17, 2026 8:01 PM - SEC Filing Form 4 BioXcel Therapeutics, For: Jun 15 Filed by: Steinhart Richard I June 17, 2026 8:01 PM - SEC Filing Form 4 BioXcel Therapeutics, For: Jun 15 Filed by: Yocca Frank June 17, 2026 8:00 PM - SEC Filing Form 4 BioXcel Therapeutics, For: Jun 15 Filed by: Mehta Vimal June 17, 2026 8:00 PM - SEC Filing Full Article List